Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Jones

Showing results (191-200 of 281) with videos related to

Pageof 29
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1991
Phase I study of combination drug purging for autologous bone marrow transplantationS D Rowley, C B Miller, S Piantadosi, et al.
Bone Marrow Transplantation|November 1, 1990
Density-gradient separation of autologous bone marrow grafts before ex vivo purging with 4-hydroperoxycyclophosphamideS D Rowley, J M Davis, S Piantadosi, et al.
Human Immunology|July 1, 1992
Autologous graft-versus-host disease: a novel approach for antitumor immunotherapyA D Hess, R J Jones, L E Morris, et al.
Journal of the National Cancer Institute|December 19, 1990
Effects of the differentiating agent hexamethylene bisacetamide on normal and myelodysplastic hematopoietic progenitorsE K Rowinsky, R C Donehower, J L Spivak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1995
Impact of in vivo administration of interleukin 3 on proliferation, differentiation, and chemosensitivity of acute myeloid leukemiaS D Gore, L J Weng, R J Jones, et al.
Leukemia & Lymphoma|October 1, 1993
Cyclosporine-induced graft-versus-host disease after autologous bone marrow transplantation for acute myeloid leukemiaA M Yeager, G B Vogelsang, R J Jones, et al.
Blood|November 11, 1992
Optimization of busulfan dosage in children undergoing bone marrow transplantation: a pharmacokinetic study of dose escalationA M Yeager, J E Wagner, M L Graham, et al.
Blood|March 15, 1990
Bryostatin 1, a unique biologic response modifier: anti-leukemic activity in vitroR J Jones, S J Sharkis, C B Miller, et al.
Blood|February 25, 1999
Resistance of paroxysmal nocturnal hemoglobinuria cells to the glycosylphosphatidylinositol-binding toxin aerolysinR A Brodsky, G L Mukhina, K L Nelson, et al.
Bone Marrow Transplantation|May 1, 1990
In vitro evaluation of combination drug purging for autologous bone marrow transplantationR J Jones, C B Miller, B A Zehnbauer, et al.
Pageof 29

Showing results (191-200 of 281) with videos related to

Sort By:
Pageof 29
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1991
Phase I study of combination drug purging for autologous bone marrow transplantationS D Rowley, C B Miller, S Piantadosi, et al.
Bone Marrow Transplantation|November 1, 1990
Density-gradient separation of autologous bone marrow grafts before ex vivo purging with 4-hydroperoxycyclophosphamideS D Rowley, J M Davis, S Piantadosi, et al.
Human Immunology|July 1, 1992
Autologous graft-versus-host disease: a novel approach for antitumor immunotherapyA D Hess, R J Jones, L E Morris, et al.
Journal of the National Cancer Institute|December 19, 1990
Effects of the differentiating agent hexamethylene bisacetamide on normal and myelodysplastic hematopoietic progenitorsE K Rowinsky, R C Donehower, J L Spivak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1995
Impact of in vivo administration of interleukin 3 on proliferation, differentiation, and chemosensitivity of acute myeloid leukemiaS D Gore, L J Weng, R J Jones, et al.
Leukemia & Lymphoma|October 1, 1993
Cyclosporine-induced graft-versus-host disease after autologous bone marrow transplantation for acute myeloid leukemiaA M Yeager, G B Vogelsang, R J Jones, et al.
Blood|November 11, 1992
Optimization of busulfan dosage in children undergoing bone marrow transplantation: a pharmacokinetic study of dose escalationA M Yeager, J E Wagner, M L Graham, et al.
Blood|March 15, 1990
Bryostatin 1, a unique biologic response modifier: anti-leukemic activity in vitroR J Jones, S J Sharkis, C B Miller, et al.
Blood|February 25, 1999
Resistance of paroxysmal nocturnal hemoglobinuria cells to the glycosylphosphatidylinositol-binding toxin aerolysinR A Brodsky, G L Mukhina, K L Nelson, et al.
Bone Marrow Transplantation|May 1, 1990
In vitro evaluation of combination drug purging for autologous bone marrow transplantationR J Jones, C B Miller, B A Zehnbauer, et al.
Pageof 29